327 filings
Page 4 of 17
8-K
yvts8py5gox4 uy5
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:12pm
8-K
bnv70or4y hrrel
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:11pm
8-K
g4va h9t967su97kmnhr
19 Jul 21
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
12:00am
S-8
ikcym0
25 Jun 21
Registration of securities for employees
4:31pm
8-K
afflkw31p2fcu
25 Jun 21
Regulation FD Disclosure
4:12pm
8-K
9rybwgnb2xs9a9ysy2y
17 Jun 21
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
4:36pm
8-K
wuu5nt88djznygs
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
DEF 14A
yzmhv5om0w2rbkygbt
10 May 21
Definitive proxy
4:06pm
10-Q
3yknibaqj4jto lrm9r1
6 May 21
Quarterly report
4:14pm
8-K
bo76rp g336aeydq
6 May 21
Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights
4:08pm
10-K/A
yekrpw
30 Apr 21
Annual report (amended)
4:16pm
PRE 14A
q4jttqtbtebaav9us
27 Apr 21
Preliminary proxy
4:32pm
8-K
b0wim3v 35qqruz9n
27 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:17pm
S-8
bezljeo3g yc5
24 Feb 21
Registration of securities for employees
4:28pm
8-K
enx7gl78
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
10-K
hqeeausp
24 Feb 21
Annual report
4:09pm
8-K
kgs 963sholo
25 Jan 21
Financial Statements and Exhibits
8:21am
6-K
50zc6iij099zq9i33zq
30 Dec 20
Material Change Report
5:30pm
6-K
8ae8w09a
21 Dec 20
Aurinia Pharmaceuticals Inc. 6-K
4:05pm